<DOC>
	<DOCNO>NCT02189850</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerance efficacy BLI800 bowel preparation prior colonoscopy pediatric patient .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability Bowel Cleansing Preparation ( BLI800 ) Pediatric Subjects Undergoing Colonoscopy</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Key Male female age 12 17 Weight 40kg Undergoing colonoscopy routinely accept indication If female , childbearing potential , subject must use acceptable form birth control remain abstinent duration study . Negative pregnancy test screening , applicable In Investigator 's judgment , caregiver mentally competent provide inform consent child participate study . Subjects know suspected ileus , impaction , severe ulcerative colitis , acute peritonitis , gastrointestinal obstruction , gastric retention ( gastroparesis ) , bowel perforation , toxic colitis megacolon . Subjects previous significant gastrointestinal surgery . Subjects increase risk bowel perforation , include connective tissue disorder , toxic dilation bowel recent bowel surgery . Subjects uncontrolled preexist electrolyte abnormality , clinically significant electrolyte abnormality base Visit 1 laboratory result Subjects bleed disorder and/or impaired platelet function , neutropenia . Subjects prior history renal , liver cardiac insufficiency Subjects require take oral medication within 3 hour dose completion dos . Subjects impaired consciousness predisposes pulmonary aspiration . Subjects tendency nausea and/or vomiting , know swallow disorder . Subjects intake substance likely affect gastrointestinal motility urinary flow rate . Subjects undergoing colonoscopy foreign body removal and/or decompression .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>colonoscopy</keyword>
	<keyword>pediatric</keyword>
</DOC>